Psychedelics

As psychedelic therapies expand, new clinics treat uncommon long-term harms

Psychedelic-assisted therapy could open a new path for treating cocaine use disorder, which has no approved medications yet

An active ingredient in magic mushrooms, psilocybin has shown early promise for treating eating disorders

The Trump administration has fast-tracked research into psychedelics, and experts say it is likely a matter of time before the drugs are used to treat minors

A survey found that more than 60 percent of respondents “strongly support” making psychedelics easier to study, reflecting a growing consensus that some could have therapeutic use

Scientists gave people a “heroic” dose of psilocybin and then looked at their brain. Here’s what happened

Tracing how psychedelics have undergone a revival in the U.S. and what the White House’s new psychedelic push means for research

At a Senate hearing on Wednesday, Robert F. Kennedy, Jr., referred to ibogaine as the most promising treatment for PTSD and depression “that anybody’s ever seen.” Does the science hold that up?

Scientists just discovered a new species of magic mushroom, Psilocybe ochraceocentrata, that appears to have shared a common ancestor with the popular Psilocybe cubensis some 1.5 million years ago

Researchers tested 12 “magic mushroom” edibles. None contained psilocybin, but most contained undisclosed ingredients, including synthetic drugs whose safety hasn’t been tested in humans

Researchers have doubted how useful AI protein-structure tool AlphaFold will be in discovering medicines—now they are learning how to deploy it effectively

Their efforts could benefit countless others in need of an end-of-life measure